Biosearch Technologies Oligo-Synthesis logo

Biosearch Technologies Oligo-Synthesis

Integrated tools. Accelerated science.

560 employees · est. 1993 · Hoddesdon, United Kingdom

VS
MEDGENOME logo

MEDGENOME

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

1011 employees · est. 2013 · Foster City, India

Biosearch Technologies Oligo-Synthesis is the older company (1993 vs 2013); MEDGENOME is the larger of the two.

Side-by-Side Comparison

Biosearch Technologies Oligo-Synthesis MEDGENOME
Founded
1993 older 2013
Headquarters
Hoddesdon, United Kingdom Foster City, India
Employees
560 1011 larger
Industry
Design, Health Care, Manufacturing Biotechnology, Health Care
Funding Stage
Not tracked yet Series D
Total Funding
Not tracked yet $1.40B
Funding Rounds
Not tracked yet 8
Services
Custom Oligo and Probe Synthesis, Nucleic Acid Extraction Services, Genotyping and Sequencing Services, Molecular Diagnostic Kit Manufacturing, Bioinformatics Analysis and Software, Custom Assay Design Genetic and Molecular Testing, Omics Solutions, Whole Exome and Genome Sequencing, Liquid Biopsy, Carrier and Hereditary Cancer Screening, Research and Multiomics Services
Target Customers
Biotech and Pharmaceutical Companies, Research Institutions, Diagnostic Laboratories, Agricultural Genomics Researchers, Healthcare Providers in Infectious Disease and Oncology Clinicians, Hospitals, Pharmaceutical Companies, Patients with Genetic Disorders, Oncology Centers, Reproductive Health Specialists
Taxonomy
Molecular Diagnostic Tools, Clinical Genomics Assays, Oligo Therapeutics, Genotyping, Genomics Workflow Support, Product Development Pipeline, Real-time Quantitative PCR, RNA FISH, Fluorophores, Dark Quenchers, DNA Sequencing, DNA Extraction, Reagents And Consumables, Next Gen Sequencing, Laboratory Services Genomic Testing, Precision Diagnostics, Next-Generation Sequencing, Rare Inherited Disorders, Oncology Genomics, Reproductive Health, Infectious Disease Diagnostics, Preventive Wellness, AI-enabled Bioinformatics, Genomic Healthcare Access, Cancer Genomics, Metabolic Disorders, Eye Disorders, Genomics Research, Immunotherapy Solutions
Website
biosearchtech.com medgenome.com
Biosearch Technologies Oligo-Synthesis logo

About Biosearch Technologies Oligo-Synthesis

LGC Biosearch Technologies, founded in 1993 and headquartered in the United Kingdom, operates at the intersection of Design, Health Care, Manufacturing, and Robotics. With its slogan "Integrated tools. Accelerated science," the company offers an extensive range of mission-critical analysis tools, re...

MEDGENOME logo

About MEDGENOME

MEDGENOME, founded in 2013, has emerged as a leader in the fields of Biotechnology and Health Care, primarily offering comprehensive genetic testing services, genomics research, and drug discovery solutions. Their headquarters is located in India, where they operate South Asia's largest CAP-accredit...

We will tell you when either one moves

BounceWatch watches Biosearch Technologies Oligo-Synthesis and MEDGENOME for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Biosearch Technologies... and MEDGENOME — by email.

Frequently Asked Questions

Biosearch Technologies Oligo-Synthesis — Integrated tools. Accelerated science.. MEDGENOME — Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biosearch Technologies Oligo-Synthesis has raised undisclosed funding while MEDGENOME has raised $1.40B.
Biosearch Technologies Oligo-Synthesis and MEDGENOME operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Biosearch Technologies Oligo-Synthesis with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Biosearch Technologies Oligo-Synthesis on 11 Mar 2026, and MEDGENOME on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy